Inverted (Endophytic) noninvasive lesions and neoplasms of the urothelium: The Cinderella group has yet to be fully exploited

European Urology

Volumn 59, Issue 2, 2011, Pages 225-230

  Montironi, Rodolfo ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c   Scarpelli, Marina ^a   Mazzucchelli, Roberta ^a   Mikuz, Gregor ^d   Kirkali, Ziya ^e   Montorsi, Francesco ^f  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e DOKUZ EYLUL UNIVERSITY   (Turkey)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER PAPILLOMA; CANCER MORPHOLOGY; CARCINOMA IN SITU; ENDOPHYTE; EPITHELIUM HYPERPLASIA; GROWTH; HUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVIEW; URINARY TRACT DISEASE; URINARY TRACT MALFORMATION; URINARY TRACT TUMOR; UROTHELIUM;

EID: 78650684466     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.11.018     Document Type: Editorial

References (31)

1. R. Montironi, R. Mazzucchelli, M. Scarpelli, A. Lopez-Beltran, and L. Cheng Morphological diagnosis of urothelial neoplasms J Clin Pathol 61 2008 3 10
2. M.B. Amin, J.A. Gómez, and R.H. Young Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases Am J Surg Pathol 21 1997 1057 1068
3. K.B. Hodges, A. Lopez-Beltran, D.D. Davidson, R. Montironi, and L. Cheng Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features Hum Pathol 41 2010 155 162
4. R. Montironi, A. Lopez-Beltran, M. Scarpelli, R. Mazzucchelli, and L. Cheng Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder Histopathology 53 2008 621 633
5. L. Cheng, J.C. Cheville, R.M. Neumann, and D.G. Bostwick Natural history of urothelial dysplasia of the bladder Am J Surg Pathol 23 1999 443 447
6. M. Birkhahn, A.P. Mitra, and A.J. Williams Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles Eur Urol 57 2010 12 20
7. M. Burger Editorial comment on: prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications Eur Urol 57 2010 858
8. L.T. Guey, M. García-Closas, and C. Murta-Nascimento Genetic susceptibility to distinct bladder cancer subphenotypes Eur Urol 57 2010 283 292
9. M. May, S. Brookman-Amissah, and J. Roigas Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications Eur Urol 57 2010 850 858
10. B.W.G. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
11. K. Yorukoglu, B. Tuna, Z. Kirkali, Re: Matthias May, Sabine Brookman-Amissah, and Jan Roigas Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications Eur Urol 58 2010 e7
12. L. Cheng, R. Montironi, D.D. Davidson, and A. Lopez-Beltran Staging and reporting of urothelial carcinoma of the urinary bladder Mod Pathol 22 Suppl 2 2009 S70 95
13. A. Lopez-Beltran, L. Cheng, and L. Andersson Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation Virchows Arch 440 2002 3 11
14. D.C. Taylor, B.S. Bhagavan, M.P. Larsen, J.A. Cox, and J.I. Epstein Papillary urothelial hyperplasia. A precursor to papillary neoplasms Am J Surg Pathol 20 1996 1481 1488
15. N. Readal, and J.I. Epstein Papillary urothelial hyperplasia: relationship to urothelial neoplasms Pathology 42 2010 360 363
16. M. Babjuk Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives Eur Urol 58 2010 191 192
17. G. Dalbagni, K. Vora, and M. Kaag Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer Eur Urol 56 2009 903 910
18. R.T. Divrik, A.F. ahin, and G. Ergör Reply from authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4 Eur Urol 58 2010 195 196
19. R.T. Divrik, A.F. ahin, Ü. Yildirim, M. Altok, and F. Zorlu Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial Eur Urol 58 2010 185 190
20. H.-M. Fritsche, M. Burger, and R.S. Svatek Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort Eur Urol 57 2010 300 309
21. G.S. Kulkarni, O.W. Hakenberg, and J.E. Gschwend An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer Eur Urol 57 2010 60 70
22. G. Novara, and V. Ficarra Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue Eur Urol 58 2010 193 194
23. B.W.G. van Rhijn, T.C.M. Zuiverloon, and A.N. Vis Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer Eur Urol 58 2010 433 441
24. L. Cheng, and D.G. Bostwick Overdiagnosis of bladder carcinoma Anal Quant Cytol Histol 30 2008 261 264
25. S. Lott, M. Wang, and S. Zhang FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations Mod Pathol 22 2009 627 632
26. M.T. Sung, G.T. Maclennan, A. Lopez-Beltran, R. Montironi, and L. Cheng Natural history of urothelial inverted papilloma Cancer 107 2006 2622 2627
27. L. Cheng, A. Lopez-Beltran, G.T. MacLennan, R. Montironi, and D.G. Bostwick Neoplasms of the urinary bladder D.G. Bostwick, L. Cheng, Urologic Surgical Pathology ed. 2. 2008 Mosby/Elsevier Philadelphia, PA, USA 289 292
28. Hodges KB, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management. BJU Int. In press. doi:10.1111/j.1464-410X.2010.09853.x.
29. T.D. Jones, S. Zhang, and A. Lopez-Beltran Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis Am J Surg Pathol 31 2007 1861 1867
30. J.I. Epstein, and M.B. Amin Urothelial neoplasms with inverted growth patterns J.I. Epstein, M.B. Amin, Biopsy Interpretation of the Bladder ed. 2. 2010 Lippincot Williams & Wilkins Philadelphia, PA, USA p.79-93
31. J.K. McKenney, and M. Vankalakunti Overview of urinary bladder neoplasms M.B. Amin, Diagnostic Pathology: Genitourinary ed. 1 2010 AMIRSYS Manitoba, Canada p. 50